Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Liên Minh Châu Âu - Tiếng Slovak - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - chrípky vírusu povrchové antigény (hemaglutinínu a neuraminidázy) kmeňa a/vietnam/1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vakcíny - aktívna imunizácia proti podtypu h5n1 vírusu chrípky a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

MYFORTIC 180 mg/1 tableta gastrorezistentna tableta Bosnia và Herzegovina - Tiếng Croatia - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

myfortic 180 mg/1 tableta gastrorezistentna tableta

novartis ba d.o.o. - mikofenolna kiselina - gastrorezistentna tableta - 180 mg/1 tableta - 1 gastrorezistentna tableta sadrži: 180 mg mikofenolne kiseline (u obliku mikofenolatnatrijuma)

MYFORTIC 360 mg/1 tableta gastrorezistentna tableta Bosnia và Herzegovina - Tiếng Croatia - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

myfortic 360 mg/1 tableta gastrorezistentna tableta

novartis ba d.o.o. - mikofenolna kiselina - gastrorezistentna tableta - 360 mg/1 tableta - 1 gastrorezistentna tableta sadrži: 360 mg mikofenolne kiseline (u obliku mikofenolatnatrijuma)